Skip to content
Illustration of the UT Tower and UT football stadium and Austin, TX skyline.

2025 Innovation Summit

3rd Annual Life Science & Healthcare Innovation Summit

Breyer Capital and UT Austin logos

A MESSAGE FROM INTERIM PRESIDENT JAMES E. DAVIS

Jim Davis

The Innovation Summit convenes leaders from the private sector and the academic world to explore advancements that could change the future of healthcare and life sciences. Throughout the two-day Summit, participants hear from, and visit with, thought leaders from across the innovation ecosystem.

Some of the 2025 Summit speakers are listed below. I hope you enjoy your time at the newly finished Innovation Tower as we explore what is possible in these important fields.


2025 FEATURED SPEAKERS

Jim Breyer
Breyer Capital

Founder and CEO of Breyer Capital, a premier venture capital firm. He has been an early investor in over 40 technology companies that have completed highly successful public offerings or mergers.

Jim Breyer
Arvind Krishna

Arvind Krishna
IBM

Chairman and Chief Executive Officer of IBM. Arvind is a business leader and technologist who has led the building and expansion of new markets for IBM in artificial intelligence, cloud and quantum computing.

Claudia Lucchinetti
Dell Medical School

Dean of Dell Medical School and Senior Vice President of Medical Affairs at UT, Dr. Lucchinetti oversees the academic medicine footprint of the University, including education, practice and research.

Claudia Lucchinetti
Diogo Rau

Diogo Rau
Eli Lilly

Diogo Rau is the Executive Vice President and Chief Information and Digital Officer at Eli Lilly and Company, leading IT, cybersecurity, digital health and advanced analytics.

Charles Taylor
The University of Texas at Austin

Founder of HeartFlow Inc, Dr. Taylor is the Moncrief Chair in Computational Medicine, Professor of Internal Medicine and Computational Engineering and Sciences and Director of the Center for Computational Medicine at UT.

Charles Taylor
Marc Tessier Lavigne

Marc Tessier-Lavigne
Xaira

Marc Tessier-Lavigne is the founding Chairman and CEO of Xaira, a biotherapeutics company applying AI to transform drug discovery. Previously, he held executive positions in the private and academic sectors.

Questions, please contact: utaustininnovationsummit@utexas.edu

Breyer Capital and UT Austin logos